搜索结果: 1-15 共查到“肿瘤学 OVARIAN CANCER”相关记录16条 . 查询时间(0.069 秒)
EARLY DETECTION OF OVARIAN CANCER USING GABOR WAVELET PHASE QUANTIZATION AND BINARY CODING
Ovarian cancer treatment
2015/5/27
Ovarian cancer is the 5th most common cancer in women, but it is the most difficult to detect in its early stages. Early detection and treatment of ovarian cancer has been shown to increase the five y...
Mechanism of tissue transglutaminase upregulation and its role in ovarian cancer metastasis
tissue transglutaminase TGF-beta ovarian cancer
2015/5/25
Ovarian cancer (OC) is a lethal disease due to metastasis and chemoresistance. Our laboratory previously reported that tissue transglutaminase (TG2) is overexpressed in OC and enhances OC peritoneal m...
New Method Increases Accuracy of Ovarian Cancer Prognosis and Diagnosis
Ovarian Cancer Prognosis Diagnosis
2015/4/29
Mathematical Technique Reveals Predictive DNA Patterns That Other Methods Missed.Nearly anyone touched by ovarian cancer will tell you: it’s devastating. It’s bad enough that cancer in almost 80 perce...
Epithelial ovarian cancer is a challenging disease to treat, with the majority of patients presenting with advanced disease. Despite aggressive surgical debulking and platinum-based chemotherapy, many...
Management of women at high familial risk for breast and ovarian cancer
high familial risk breast and ovarian cancer
2015/3/24
Women with a strong family history of breast and/or ovarian cancer have a greatly increased risk for the development of these diseases. The key question for these women is what they can do to ameliora...
The integrated, multidisciplinary clinic: a new model for the ongoing management of women at high genetic risk for breast and ovarian cancer
risk management
2015/3/18
An important minority of Australian women have a strong hereditary predisposition for the development of breast and/or
ovarian cancer. Evidence-based cancer risk reduction strategies for this group a...
MANAGEMENT OF WOMEN AT INCREASED GENETIC RISK OF OVARIAN CANCER
INCREASED GENETIC RISK MANAGEMENT
2015/3/13
Epidemiological studies have identified family history as one of
the major risk factors for epithelial ovarian cancer (subsequently
referred to as “ovarian cancer”) and in recent years we have
gain...
MOLECULAR PROGNOSIS OF EPITHELIAL OVARIAN CANCER: OBSERVATIONS FROM CURRENT LITERATURE
MOLECULAR PROGNOSIS CANCER
2015/3/13
The most effective
chemotherapy agent against ovarian cancer is cisplatin – also
used for lung, head and neck, bladder and testicular cancers.
Response rates to this drug vary from 40%-80% and it i...
Screening in ovarian cancer
ovarian cancer world
2015/3/13
Ovarian cancer is the leading cause of death from
gynaecological cancer in the developed world, comprising 5%
of all cancer-related deaths in women. The high mortality rate
has been attributed prim...
Ovarian cancer is the leading cause of death from
gynaecological cancers in Australia. In recognition of the
impact of ovarian cancer on Australian women, in September
2001 the Federal Government c...
Although in Australia the lifetime risk of ovarian cancer is only
one in 107, it is the fifth most common cause of cancer death in
Australian women1
. Over 90% of ovarian malignancies are
thought ...
Study challenges anecdotal evidence of diagnostic delay in ovarian cancer
Study anecdotal evidence of diagnostic delay ovarian cancer
2010/10/13
Most women with ovarian cancer in Australia are investigated and diagnosed promptly, despite anecdotal suggestions to the contrary, according to research published in the Medical Journal of Australia....
Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study Modares Gilani M
Ovarian cancer recurrence gemcitabin carboplatin survival
2009/12/9
Background: Ovarian cancer is the leading cause of death among all gynecologic cancers in developed countries. The standard treatment for advanced ovarian cancer consists of cytoreductive surgery asso...
Nanoparticles target ovarian cancer--New gene therapy technique could fight late-stage tumors
ovarian cancer gene therapy technique late-stage tumors
2009/8/3
Tiny particles carrying a killer gene can effectively suppress ovarian tumor growth in mice, according to a team of researchers from MIT and the Lankenau Institute.The findings could lead to a new tre...
期刊信息
篇名
Reversing drug resistance in the ovarian cancer cell line SKOV3/MDR-1 in vitro by antisense oligodeoxy-nucleotide.
语种
英文
撰写或编译
撰写
作者
PAN Lingya,TONG Ying,JIN Ying,et al
第一作者单位
中国医学科学院北京协和医院,军事...